
Susanna Moore
Examiner (ID: 4754)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624 |
| Total Applications | 1838 |
| Issued Applications | 1086 |
| Pending Applications | 196 |
| Abandoned Applications | 608 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16925233
[patent_doc_number] => 11046694
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-29
[patent_title] => Compounds and methods for treating bacterial infections
[patent_app_type] => utility
[patent_app_number] => 16/611065
[patent_app_country] => US
[patent_app_date] => 2018-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 26736
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16611065
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/611065 | Compounds and methods for treating bacterial infections | May 7, 2018 | Issued |
Array
(
[id] => 16720060
[patent_doc_number] => 20210087207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => PROCESS FOR PREPARING CHIRAL 2,3-DIHYDROTHIAZOLO[3,2-A]PYRIMIDIN-4-IUM COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/610186
[patent_app_country] => US
[patent_app_date] => 2018-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610186
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/610186 | Process for preparing chiral 2,3-dihydrothiazolo[3,2-A] pyrimidin-4-ium compounds | May 1, 2018 | Issued |
Array
(
[id] => 15898399
[patent_doc_number] => 20200148718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => PHARMACEUTICAL-GRADE 20-HYDROXYECDYSONE EXTRACT, USE OF SAME AND PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/609208
[patent_app_country] => US
[patent_app_date] => 2018-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4166
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609208
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/609208 | PHARMACEUTICAL-GRADE 20-HYDROXYECDYSONE EXTRACT, USE OF SAME AND PREPARATION THEREOF | Apr 29, 2018 | Abandoned |
Array
(
[id] => 14791427
[patent_doc_number] => 10398699
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-03
[patent_title] => Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/960069
[patent_app_country] => US
[patent_app_date] => 2018-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73029
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15960069
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/960069 | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors | Apr 22, 2018 | Issued |
Array
(
[id] => 16222646
[patent_doc_number] => 20200247762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => K-RAS MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/605643
[patent_app_country] => US
[patent_app_date] => 2018-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16605643
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/605643 | K-Ras modulators | Apr 19, 2018 | Issued |
Array
(
[id] => 13443995
[patent_doc_number] => 20180273540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => PYRAZOLO[1,5-A]PYRIMIDINE-5,7-DIAMINE COMPOUNDS AS CDK INHIBITORS AND THEIR THERAPEUTIC USE
[patent_app_type] => utility
[patent_app_number] => 15/941063
[patent_app_country] => US
[patent_app_date] => 2018-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15941063
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/941063 | Pyrazolo[1,5-A]pyrimidine-5,7-diamine compounds as CDK inhibitors and their therapeutic use | Mar 29, 2018 | Issued |
Array
(
[id] => 16459464
[patent_doc_number] => 10842792
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-24
[patent_title] => Deuterated baricitinib
[patent_app_type] => utility
[patent_app_number] => 15/940964
[patent_app_country] => US
[patent_app_date] => 2018-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7292
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15940964
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/940964 | Deuterated baricitinib | Mar 29, 2018 | Issued |
Array
(
[id] => 13440589
[patent_doc_number] => 20180271837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => ISOXAZOLE CARBOXAMIDE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/934176
[patent_app_country] => US
[patent_app_date] => 2018-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 230
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15934176
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/934176 | ISOXAZOLE CARBOXAMIDE COMPOUNDS AND USES THEREOF | Mar 22, 2018 | Abandoned |
Array
(
[id] => 14913537
[patent_doc_number] => 10428074
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-01
[patent_title] => Pyrrole heteroaryl ring derivative and method of use thereof
[patent_app_type] => utility
[patent_app_number] => 15/933371
[patent_app_country] => US
[patent_app_date] => 2018-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31924
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15933371
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/933371 | Pyrrole heteroaryl ring derivative and method of use thereof | Mar 21, 2018 | Issued |
Array
(
[id] => 16876826
[patent_doc_number] => 11026946
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => Pharmacologically active alicyclic-substituted pyrazolo[1,5-a]pyrimidine derivatives
[patent_app_type] => utility
[patent_app_number] => 16/493453
[patent_app_country] => US
[patent_app_date] => 2018-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9657
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16493453
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/493453 | Pharmacologically active alicyclic-substituted pyrazolo[1,5-a]pyrimidine derivatives | Mar 11, 2018 | Issued |
Array
(
[id] => 15831719
[patent_doc_number] => 20200131141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => CHEMICAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/493816
[patent_app_country] => US
[patent_app_date] => 2018-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24495
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16493816
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/493816 | Urea derivatives and methods of use thereof | Mar 11, 2018 | Issued |
Array
(
[id] => 12884881
[patent_doc_number] => 20180186802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => COMPOUNDS AND COMPOSITIONS AS TOLL-LIKE RECEPTOR 7 AGONISTS
[patent_app_type] => utility
[patent_app_number] => 15/906424
[patent_app_country] => US
[patent_app_date] => 2018-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22926
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 271
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15906424
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/906424 | Compounds and compositions as toll-like receptor 7 agonists | Feb 26, 2018 | Issued |
Array
(
[id] => 12862126
[patent_doc_number] => 20180179216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => SUBSTITUTED [1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL COMPOUNDS AS PDE2 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/905672
[patent_app_country] => US
[patent_app_date] => 2018-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38544
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15905672
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/905672 | Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitors | Feb 25, 2018 | Issued |
Array
(
[id] => 16558447
[patent_doc_number] => 20210003596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => CHEMILUMINESCENT ANDROSTENEDIONE CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 16/488524
[patent_app_country] => US
[patent_app_date] => 2018-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13015
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16488524
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/488524 | CHEMILUMINESCENT ANDROSTENEDIONE CONJUGATES | Feb 22, 2018 | Pending |
Array
(
[id] => 16558447
[patent_doc_number] => 20210003596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => CHEMILUMINESCENT ANDROSTENEDIONE CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 16/488524
[patent_app_country] => US
[patent_app_date] => 2018-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13015
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16488524
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/488524 | CHEMILUMINESCENT ANDROSTENEDIONE CONJUGATES | Feb 22, 2018 | Pending |
Array
(
[id] => 16206484
[patent_doc_number] => 20200239474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => PYRROLO-PYRIMIDINE DERIVATIVE COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME COMPOUND AS EFFECTIVE INGREDIENT FOR PREVENTING OR TREATING PROTEIN KINASE-RELATED DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/488194
[patent_app_country] => US
[patent_app_date] => 2018-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21648
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 439
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16488194
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/488194 | Pyrrolo-pyrimidine derivative compound, preparation method therefor, and pharmaceutical composition comprising same compound as effective ingredient for preventing or treating protein kinase-related disease | Feb 21, 2018 | Issued |
Array
(
[id] => 13357191
[patent_doc_number] => 20180230135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => 3-INDOLYL FURANOIDS AS INHIBITORS OF MATRIX METALLOPROTEINASE-9 FOR PREVENTION OF GASTRIC ULCER AND OTHER INFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/897688
[patent_app_country] => US
[patent_app_date] => 2018-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7060
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15897688
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/897688 | 3-indolyl furanoids as inhibitors of matrix metalloproteinase-9 for prevention of gastric ulcer and other inflammatory diseases | Feb 14, 2018 | Issued |
Array
(
[id] => 12813082
[patent_doc_number] => 20180162864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => PYRROLOPYRIMIDINE COMPOUND OR SALT THEREOF AND COMPOSITIONS CONTAINING THE PYRROLOPYRIMIDINE COMPOUND OR SALT THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/890470
[patent_app_country] => US
[patent_app_date] => 2018-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42134
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 377
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15890470
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/890470 | Pyrrolopyrimidine compound or salt thereof and compositions containing the pyrrolopyrimidine compound or salt thereof | Feb 6, 2018 | Issued |
Array
(
[id] => 12790546
[patent_doc_number] => 20180155351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES
[patent_app_type] => utility
[patent_app_number] => 15/886014
[patent_app_country] => US
[patent_app_date] => 2018-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26318
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15886014
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/886014 | PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES | Jan 31, 2018 | Abandoned |
Array
(
[id] => 15178053
[patent_doc_number] => 20190359618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => COMPOUNDS FOR INHIBITING LRRK2 KINASE ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/480762
[patent_app_country] => US
[patent_app_date] => 2018-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29721
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480762
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480762 | Compounds for inhibiting LRRK2 kinase activity | Jan 22, 2018 | Issued |